Hmmm, but it hasn't gotten past Phase I after almost 8 years? An HSV vaccine would be a real moneymaker so I find it hard to believe that there isn't enough money floating around for it.
A couple of mRNA HSV vaccines appear to be at the Phase I trial stage.
I'd pay a lot for one, even if it was out of my pocket. Not because of the annoyance of cold sores, but because I fear what these things trigger in the long term. As there is more and more research pinpointing HPV, HSV, Eppstein-Barr and Herpes Zoster, et al causing Alzheimers and auto-immune disorders down the road.
I personally find all this focus on mRNA to be disappointing. mRNA vaccines appear to be relatively easy to develop and produce, but I see no particular evidence that they’re good. With the efficacy numbers they seem to be currently showing against Covid, it’s not clear they would have made it through trials.
Your statement is completely contradicted by the actual vaccine development.
There were a LOT of Covid vaccines with different techniques and mechanisms in development simultaneously. Nobody knew a priori which vaccine would work so we funded the hell out of all of them.
mRNA came out on top relative to all the other options at 95% plus--it wasn't even close. Sinovac (inactivated virus) was at about 50% effectiveness. Novavax (protein subunit) was about 75% effectiveness and somewhat less in the Hispanic population (not understood why). Oxford/AZ/J&J/Gamelya were about 75% but had sufficient side effect to be troublesome.
And, to be fair, any of these vaccines would be in general use if we didn't have the others. The only reason why the viral vector vaccines (Oxford/AZ/J&J/Gamelaya) got pulled is because we had other options (effectively, they fail a Phase III trial since alternatives exist).
Finally, mRNA vaccines are NOT easy to produce. The fact that these things have to be held at -70C or -20C shows that they are quite complex. Contrast to the Sinovac vaccine which lasts forever with standard refrigeration.
The medical establishment would much rather use something like Sinovac; it's quite unfortunate that it just doesn't work that well. This is not surprising--there really wasn't any progress against other Coronavirii (common cold), either, until mRNA.
A couple of mRNA HSV vaccines appear to be at the Phase I trial stage.